The largest community of pharma leaders

Dyne Therapeutics Appoints Catherine Stehman-Breen to its Board of Directors

CAMBRIDGE, Mass.–(BUSINESS WIRE)–Dyne Therapeutics today announced the appointment of Catherine Stehman-Breen, M.D., to its Board of Directors. http://www.businesswire.com/news/home/20190628005028/en/Dyne-Therapeutics-Appoints-Catherine-Stehman-Breen-Board-Directors/?feedref=JjAwJuNHiystnCoBq_hl-WBlLQO14j4QZPTyX5CYOnwC4VjN53jumZRlnzhBoBxGrCOi9QzgjCezTS3Nw_X6kJUrpSBm-Hav1w-UkdSlG3ltkRSnqzf6ourQGu_UA28CzZCGORvG0LE20YOvo49uqw==

Recent Articles

2020 Call for Writers

Are you looking to inspire others in the pharma industry through your writing? You’re invited to submit your articles to become a Featured Writer for The Pharmaceutical Marketing Group website.